SCHEMBL23948142

SCHEMBL23948142

CCOC(=O)c1cnc(SC)nc1NC1CCOCC1F

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.52
SYK P43405 2/20 0.50
MAPK1 P28482 2/20 0.49
HTT P42858 1/20 0.49
MAPT P10636 5/20 0.48
LMNA P02545 3/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
FOS P01100 1/20 0.48
JUN P05412 1/20 0.48
NFKB1 P19838 1/20 0.48
NFKB2 Q00653 1/20 0.48
RELA Q04206 1/20 0.48
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
TDP1 Q9NUW8 2/20 0.45
POLB P06746 1/20 0.45
HPGD P15428 2/20 0.43
PDE4B Q07343 3/20 0.42
NR2F2 P24468 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29502030 1.00 ALDH1A1 (0.52) ALDH1A1SYKMAPK1HTTMAPT
SCHEMBL5744853 0.86 ALDH1A1 (0.55) ALDH1A1SYKMAPK1HTTMAPT
SCHEMBL5744856 0.86 ALDH1A1 (0.55) ALDH1A1SYKMAPK1HTTMAPT
SCHEMBL23948144 0.86 IRAK4 (0.38) SYKMAPK1MEN1KMT2APDE4B
SCHEMBL29502000 0.84 ALDH1A1 (0.57) ALDH1A1SYKMAPK1HTTMAPT
SCHEMBL4157935 0.84 ALDH1A1 (0.57) ALDH1A1SYKMAPK1HTTMAPT
SCHEMBL19886120 0.83 ALDH1A1 (0.56) ALDH1A1SYKMAPK1HTTMAPT
SCHEMBL22860170 0.82 ALDH1A1 (0.55) ALDH1A1SYKMAPK1HTTMAPT
SCHEMBL4405587 0.80 ALDH1A1 (0.63) ALDH1A1SYKMAPK1HTTMAPT
SCHEMBL22860738 0.79 ALDH1A1 (0.56) ALDH1A1SYKMAPK1HTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114315834-B Imidazolone derivatives and their use in medicine 成都百裕制药股份有限公司 2024-01-05 CN disclosed
US-20230165867-A1 IMIDAZOLIDINONE DERIVATIVES AND MEDICAL USE THEREOF KANGBAIDA (SICHUAN) BIOTECHNOLOGY CO., LTD. (CN) 2023-06-01 US disclosed
US-20230165867-A1 IMIDAZOLIDINONE DERIVATIVES AND MEDICAL USE THEREOF KANGBAIDA (SICHUAN) BIOTECHNOLOGY CO., LTD. (CN) 2023-06-01 US disclosed
US-20230165867-A1 IMIDAZOLIDINONE DERIVATIVES AND MEDICAL USE THEREOF KANGBAIDA (SICHUAN) BIOTECHNOLOGY CO., LTD. (CN) 2023-06-01 US disclosed
EP-4137491-A1 IMIDAZOLINONE DERIVATIVE AND USE THEREOF IN MEDICINE Chengdu Baiyu Pharmaceutical Co., Ltd. (CN) 2023-02-22 EP disclosed
EP-4137491-A1 IMIDAZOLINONE DERIVATIVE AND USE THEREOF IN MEDICINE Chengdu Baiyu Pharmaceutical Co., Ltd. (CN) 2023-02-22 EP disclosed
CN-114315834-A Imidazolidinone derivatives and their use in medicaments 成都百裕制药股份有限公司 2022-04-12 CN disclosed
WO-2021209055-A1 IMIDAZOLINONE DERIVATIVE AND USE THEREOF IN MEDICINE 成都百裕制药股份有限公司 2021-10-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230165867-A1 IMIDAZOLIDINONE DERIVATIVES AND MEDICAL USE THEREOF SYMPK, PAICS, CYP2C9 ALDH1A1 702/4885SYK 601/4885MAPK1 1665/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.